NanoHybrids Corporation, a provider of nanotechnology-based contrast agents, announces the launch of its new website and premium product line of gold nanoparticles specially designed to improve imaging results.
The company's initial technology platform was developed in collaboration with researchers from the Biomedical Engineering Department at The University of Texas at Austin and M.D. Anderson Cancer Center.
NanoHybrids' offerings include an exclusive line of silica-coated gold nanorods that are quickly gaining popularity as contrast agents in photoacoustic (optoacoustic) imaging. As opposed to current preclinical imaging contrast agents on the market, NanoHybrids' silica-coated nanorods resist melting and shape distortion even when subjected to extreme heat via focused laser beams.
In addition to providing this enhanced thermodynamic stability, the silica coating also facilitates better heat transfer to the surrounding fluid, thus dramatically increasing signal strength. Overall, these benefits make the company's silica-coated gold nanorods an excellent contrast agent for not only in vitro and in vivo photoacoustic imaging, but also many other applications involving continuous or pulsed lasers.